Bossers, Sebastiaan M. http://orcid.org/0000-0002-2396-2777
Mansvelder, Floor
Loer, Stephan A.
Boer, Christa
Bloemers, Frank W.
Van Lieshout, Esther M. M.
Den Hartog, Dennis
Hoogerwerf, Nico
van der Naalt, Joukje
Absalom, Anthony R.
Schwarte, Lothar A.
Twisk, Jos W. R.
Schober, Patrick
de Boer, Anne
Goslings, Johannes C.
van Helden, Sven H.
Hesselink, Danique
van Aken, Gijs
Beishuizen, Albertus
Egberink, Rolf E.
ter Bogt, Nancy
de Jongh, Mariska A. C.
Lansink, Koen
Lansink, Koen
Roks, Gerwin
Joosse, Pieter
Ponsen, Kees J.
van Spengler, Lukas L.
Asper, Stasja
Peerdeman, Saskia M.
Houmes, Robert J.
van Ditshuizen, Jan
van Voorden, Tea
Edwards, Michael J. R.
Dercksen, Bert
Spanjersberg, Rob
Venema, Lieneke
Weelink, Ellen
Reininga, Inge H. F.
Innemee, Gerard
de Visser, Matthijs
de Leeuw, Marcel A.
Kooij, Fabian O.
,
Funding for this research was provided by:
Achmea (Grant Z644, Grant Z644)
Hersenstichting (Grant F2010(1)-14)
Article History
Received: 26 October 2022
Accepted: 19 February 2023
First Online: 19 April 2023
Declarations
:
: SMB reported receiving grants from Achmea Healthcare Foundation during the conduct of the study. ARA reported receiving grants and personal fees from Becton Dickson and The Medicines Company; grants from Draeger; sponsor-initiated and funded phase 1 research from Rigel; and personal fees from PAION, Janssen Pharma, Ever Pharma, and Philips outside the submitted work. PS reported receiving grants from Dutch Brain Foundation and Achmea Healthcare Foundation during the conduct of the study. No other disclosures were reported.